chr15-42399641-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000070.3(CAPN3):c.1343G>T(p.Arg448Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R448C) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000070.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CAPN3 | NM_000070.3 | c.1343G>T | p.Arg448Leu | missense_variant | 10/24 | ENST00000397163.8 | NP_000061.1 | |
CAPN3 | NM_024344.2 | c.1343G>T | p.Arg448Leu | missense_variant | 10/23 | NP_077320.1 | ||
CAPN3 | NM_173087.2 | c.1199G>T | p.Arg400Leu | missense_variant | 9/21 | NP_775110.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CAPN3 | ENST00000397163.8 | c.1343G>T | p.Arg448Leu | missense_variant | 10/24 | 1 | NM_000070.3 | ENSP00000380349.3 | ||
ENSG00000258461 | ENST00000495723.1 | n.*1139G>T | non_coding_transcript_exon_variant | 14/26 | 2 | ENSP00000492063.1 | ||||
ENSG00000258461 | ENST00000495723.1 | n.*1139G>T | 3_prime_UTR_variant | 14/26 | 2 | ENSP00000492063.1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Feb 21, 2024 | - - |
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 24, 2023 | Variant summary: CAPN3 c.1343G>T (p.Arg448Leu) results in a non-conservative amino acid change located in the calpain large subunit, domain III (IPR022682) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 235170 control chromosomes (gnomAD). c.1343G>T has been reported in the literature as a biallelic genotype in individuals affected with autosomal recessive Limb-Girdle Muscular Dystrophy, including at least one case where it was confirmed to be in trans with a pathogenic variant (e.g. Luo_2012, Dai_2015, Yu_2017, Chakravorty_2021, Zhong_2021). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. However, it has been reported in a homozygous individual who exhibited a loss of calpain-3 expression as determined by Western blotting (Feng_2018) and there are multiple other missense variants affecting the same amino acid (e.g. R448G, R448C, R448H) which have been classified as pathogenic, suggesting Arg448 is important for protein function and alterations to this residue are likely to be disease-causing. The following publications have been ascertained in the context of this evaluation (PMID: 33250842, 25987458, 29797799, 22926650, 28403181, 32994280). One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014 and has classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Abnormality of the musculature Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Kariminejad - Najmabadi Pathology & Genetics Center | Jul 10, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at